Drug Shortage Report for SANDOZ PREGABALIN

Last updated on 2022-05-24 History
Report ID 160289
Drug Identification Number 02390833
Brand name SANDOZ PREGABALIN
Common or Proper name PREGABALIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PREGABALIN
Strength(s) 75MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 500HGC BO
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-10
Estimated end date 2022-05-20
Actual end date 2022-05-24
Shortage status Resolved
Updated date 2022-05-24
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-05-24 French Compare
v3 2022-05-24 English Compare
v2 2022-05-10 French Compare
v1 2022-05-10 English Compare

Showing 1 to 4 of 4